{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:10:03Z","timestamp":1756307403812,"version":"3.44.0"},"reference-count":34,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2023,4,28]]},"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:p>A man in his mid-30s presented to the emergency department with a 1-week history of fatigue, loss of appetite, fever and productive (yellow) cough. This progressed to requiring admission to intensive care needing a oxygen therapy via high-flow nasal cannula for acute hypoxaemic respiratory failure. He had recently started vortioxetine for major depressive disorder, and his acute symptoms correlated with an increase in the dose of vortioxetine. For more than 20 years, rare but consistent reports of serotonergic medications have been implicated in eosinophilic pulmonary conditions. During this same period, serotonergic medications have become a mainstay solution for a wide range of depressive symptoms and disorders. This is the first report of an eosinophilic pneumonia-like syndrome occurring while consuming the novel serotonergic medication vortioxetine.<\/jats:p>","DOI":"10.1136\/bcr-2022-254254","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T13:21:28Z","timestamp":1685020888000},"page":"e254254","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Acute eosinophilic pneumonia-like syndrome post-initiation of vortioxetine"],"prefix":"10.1136","volume":"16","author":[{"given":"Tanya Marie","family":"O'Brien","sequence":"first","affiliation":[{"name":"Pharmacy, Eastern Health, St. John's, Newfoundland and Labrador, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"key":"2025082707382804000_16.5.e254254.1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1023\/A:1008727421475","article-title":"Acute eosinophilic pneumonia associated with antidepressant agents","volume":"21","author":"Barn\u00e9s","year":"1999","journal-title":"Pharm World Sci"},{"key":"2025082707382804000_16.5.e254254.2","first-page":"651","article-title":"Risperidone-Induced acute eosinophilic pneumonia","volume":"27","author":"Rizos","year":"2013","journal-title":"In Vivo"},{"key":"2025082707382804000_16.5.e254254.3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/17460441.2019.1546691","article-title":"Vortioxetine: a novel antidepressant for the treatment of major depressive disorder","volume":"14","author":"Gonda","year":"2019","journal-title":"Expert Opin Drug Discov"},{"key":"2025082707382804000_16.5.e254254.4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00007611-200093060-00016","article-title":"Pleural fluid and serum eosinophilia: association with fluoxetine hydrochloride","volume":"93","author":"Behnia","year":"2000","journal-title":"South Med J"},{"key":"2025082707382804000_16.5.e254254.5","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00.15120500"},{"key":"2025082707382804000_16.5.e254254.6","doi-asserted-by":"crossref","DOI":"10.1378\/chest.06-1659","article-title":"Eosinophilic pneumonia due to duloxetine","volume":"131","author":"Espeleta","year":"2007","journal-title":"Chest"},{"key":"2025082707382804000_16.5.e254254.7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.genhosppsych.2011.03.010","article-title":"Venlafaxine-induced acute eosinophilic pneumonia","volume":"33","author":"Tsigkaropoulou","year":"2011","journal-title":"Gen Hosp Psychiatry"},{"key":"2025082707382804000_16.5.e254254.8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2174\/1574886313666180402150200","article-title":"Sertraline-induced acute eosinophilic pneumonia","volume":"13","author":"Muftah","year":"2018","journal-title":"Curr Drug Saf"},{"key":"2025082707382804000_16.5.e254254.9","unstructured":"Lexicomp Online . Citalopram: drug information. uptodate. Waltham, MA: UpToDate, Inc. Available: https:\/\/online.lexi.com [Accessed 31 Mar 2023]."},{"key":"2025082707382804000_16.5.e254254.10","unstructured":"Lexicomp Online . Escitalopram: drug information. uptodate. Waltham, MA: UpToDate, Inc. Available: https:\/\/online.lexi.com [Accessed 31 Mar 2023]."},{"key":"2025082707382804000_16.5.e254254.11","unstructured":"Lexicomp Online . Fluoxetine: drug information. uptodate. Waltham, MA: UpToDate, Inc. Available: https:\/\/online.lexi.com [Accessed 31 Mar 2023]."},{"key":"2025082707382804000_16.5.e254254.12","unstructured":"Lexicomp Online . Fluvoxamine: drug information. uptodate. Waltham, MA: UpToDate, Inc. Available: https:\/\/online.lexi.com [Accessed 31 Mar 2023]."},{"key":"2025082707382804000_16.5.e254254.13","unstructured":"Lexicomp Online . Paroxetine: drug information. uptodate. Waltham, MA: UpToDate, Inc. Available: https:\/\/online.lexi.com [Accessed 31 Mar 2023]."},{"key":"2025082707382804000_16.5.e254254.14","unstructured":"Lexicomp Online . Sertraline: drug information. uptodate. Waltham, MA: UpToDate, Inc. Available: https:\/\/online.lexi.com [Accessed 31 Mar 2023]."},{"key":"2025082707382804000_16.5.e254254.15","unstructured":"Lexicomp Online . Vortioxetine: drug information. uptodate. Waltham, MA: UpToDate, Inc. Available: https:\/\/online.lexi.com [Accessed 31 Mar 2023]."},{"key":"2025082707382804000_16.5.e254254.16","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.573477"},{"key":"2025082707382804000_16.5.e254254.17","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.03.013"},{"key":"2025082707382804000_16.5.e254254.18","doi-asserted-by":"crossref","first-page":"8137","DOI":"10.3748\/wjg.v22.i36.8137","article-title":"Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome","volume":"22","author":"Jin","year":"2016","journal-title":"WJG"},{"key":"2025082707382804000_16.5.e254254.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2008.07.016"},{"key":"2025082707382804000_16.5.e254254.20","first-page":"268","article-title":"Serotonin is a sword and a shield of the bowel: serotonin plays offense and defense","volume":"123","author":"Gershon","year":"2012","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"2025082707382804000_16.5.e254254.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2009.01370.x"},{"key":"2025082707382804000_16.5.e254254.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.03.085"},{"key":"2025082707382804000_16.5.e254254.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1916433"},{"key":"2025082707382804000_16.5.e254254.24","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-2669"},{"key":"2025082707382804000_16.5.e254254.25","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.4103\/jfmpc.jfmpc_831_21","article-title":"Agreement between WHO-UMC causality scale and the naranjo algorithm for causality assessment of adverse drug reactions","volume":"10","author":"Shukla","year":"2021","journal-title":"J Family Med Prim Care"},{"key":"2025082707382804000_16.5.e254254.26","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.6.3599"},{"key":"2025082707382804000_16.5.e254254.27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054840","article-title":"Regulation of serotonin-induced trafficking and migration of eosinophils","volume":"8","author":"Kang","year":"2013","journal-title":"PLoS One"},{"key":"2025082707382804000_16.5.e254254.28","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00000211"},{"key":"2025082707382804000_16.5.e254254.29","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/JCP.0b013e31820fbecd","article-title":"Acute eosinophilic pneumonia after venlafaxine overdose","volume":"31","author":"Paparrigopoulos","year":"2011","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"2025082707382804000_16.5.e254254.30","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.rmr.2012.01.006","article-title":"Clomipramine hypersensitivity with predominantly pulmonary involvement","volume":"29","author":"Gallego","year":"2012","journal-title":"Revue Des Maladies Respiratoires"},{"key":"2025082707382804000_16.5.e254254.31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/WNF.0b013e31823da9a8","article-title":"Paroxetine-associated hypereosinophilia may clinically resemble a panic attack","volume":"35","author":"Yasui-Furukori","year":"2012","journal-title":"Clinical Neuropharmacology"},{"key":"2025082707382804000_16.5.e254254.32","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-207379","article-title":"Eosinophilic pneumonia presenting as life-threatening ARDS","volume":"2015","author":"Maia","year":"2015","journal-title":"BMJ Case Reports"},{"key":"2025082707382804000_16.5.e254254.33","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009996","article-title":"Olanzapine-Induced peripheral eosinophilia and eosinophilic pleural effusion: a case report","volume":"97","author":"Huang","year":"2018","journal-title":"Medicine"},{"key":"2025082707382804000_16.5.e254254.34","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.rmr.2020.11.012","article-title":"Sertraline-induced chronic eosinophilic pneumonia","volume":"38","author":"Brancaleone","year":"2021","journal-title":"Revue Des Maladies Respiratoires"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2022-254254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T14:38:37Z","timestamp":1756305517000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2022-254254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5,25]]},"published-print":{"date-parts":[[2023,5]]}},"alternative-id":["10.1136\/bcr-2022-254254"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2022-254254","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2023,5]]}}}